Mydecine Innovations Group Inc. announced the appointment of Dr. Victoria Hale to the company's Board of Directors. Dr. Hale is a pharmaceutical scientist and executive, as well as a global health social entrepreneur. She currently serves as Chair of the Board of the Multidisciplinary Association for Psychedelic Studies (MAPS).
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.013 USD | +5.69% | +15.04% | -12.75% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.75% | 803K | |
+22.15% | 46.56B | |
+44.87% | 41.67B | |
-2.37% | 41.16B | |
+33.84% | 32.4B | |
+20.42% | 28.18B | |
-6.35% | 28.1B | |
+48.83% | 14.52B | |
+45.00% | 13.74B | |
+0.06% | 12.17B |
- Stock Market
- Equities
- MYCOF Stock
- News Mydecine Innovations Group Inc.
- Mydecine Innovations Group Inc. Appoints Victoria Hale as Newest Independent Board Member